Mast cells in chronic rejection of human renal allografts

Virchows Archiv

Volumn 437, Issue 2, 2000, Pages 167-172

  Pardo, Javier ^a   Diaz, Luisa ^a   Errasti, Pedro ^a   Idoate, Michel ^a   De Alava, Enrique ^a   Sola, Iosu ^a   Lozano, Lola ^a   Panizo, Angel ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Chronic rejection; Interstitial fibrosis; Mast cell; Organ transplantation; Renal allograft

Indexed keywords

MONOCLONAL ANTIBODY; ONCOPROTEIN; TRYPTASE;

ADULT; ARTICLE; AUTOPSY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT REJECTION; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY MEDULLA; MALE; MAST CELL; NEPHRECTOMY; PRIORITY JOURNAL;

EID: 0033898451     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000211     Document Type: Article

References (42)

1. 1. Arber DA, Tamayo R, Weiss LM (1998) Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 29: 498-504
2. 2. Atkinson JB, Harlan CW, Harlan GC, Virmani R (1994) The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 25:154-159
3. 3. Barth C, Von Menges A, Zanker B, Lammerding P, Stachowski J, Baldamus CA (1996) Restricted T cell V beta repertoire in renal allografts during acute and chronic rejection. Kidney Int 50: 2020-2026
4. 4. Burke BA, Chavers BM, Gillingham KJ, Kashtan CE, Manivel JC, Mauer SM, Nevins TE, Matas AJ (1995) Chronic renal allograft rejection in the first 6 months posttransplant. Transplantation 60:1413-1417
5. 5. Cotran R, Kumar V, Collins T (1999) Diseases of immunity. In: Robbins' Pathologic basis of disease. Saunders, Philadelphia, pp 196-199
6. 6. De Heer E, Davidoff A, van der Wal A, van Geest M, Paul LC (1994) Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest 70:494-502
7. 7. Dimitriadou V, Koutsilieris M (1997) Mast cell-tumor cell interactions: for or against tumour growth and metastasis? Anticancer Res 17:1541-1549
8. 8. Dodd SM (1999) Chronic allograft nephropathy: the inevitable outcome of renal transplantation? Curr Top Pathol 92:37-60
9. 9. Ehara T, Shigematsu H (1998) Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int 54: 1675-1683
10. 10. Eknoyan G, McDonald MA, Appel D, Truong LD (1990) Chronic tubulo-interstial nephritis: correlation between structural and functional findings. Kidney Int 38:736-743
11. 11. Escribano LM, Gabriel LC, Villa E, Navarro JL (1987) Endogenous peroxidase activity in human cutaneous and adenoidal mast cells. J Histochem Cytochem 35: 213-220
12. 12. Fritz P, Muller J, Reiser H, Saal JG, Hadam M, Tuczek HV, Wegner G, Laschner W (1986) Avidin - peroxidase. A new mast cell staining method. Acta Histochem [Suppl] 32:235-239
13. 13. Galli SJ (1993) New concepts about the mast cell. N Engl J Med 328:257-265
14. 14. Galli SJ, Wershil BK (1996) The two faces of the mast cell. Nature 381:21-22
15. 15. Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J, Ren S, Schwartz LB, Korn JH (1997) Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 158:2310-2317
16. 16. Hebda PA, Collins MA, Tharp-MD (1993) Mast cell and myofibroblast in wound healing. Dermatol Clin 11:685-696
17. 17. Hiromura K, Kurosawa M, Yano S, Naruse T (1998) Tubulointerstitial mast cell infiltration in glomerulonephritis. Am J Kidney Dis 32:593-599
18. 18. Horny HP, Ruck P, Xiao JC, Kaiserling E (1993) Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage-associated antibodies, with special reference to the recently developed monoclonal antibody PG-M1. Hum Pathol 24:355-358
19. 19. Hostetter TH (1994) Chronic transplant rejection. Kidney Int 46:266-279
20. 20. Huang C, Sali A, Stevens RL (1998) Regulation and function of mast cell proteases in inflammation. J Clin Immunol 18:169-183
21. 21. Humar A, Kerr S, Hassoun A, Granger D, Suhr B, Matas A (1999) The association between acute rejection and chronic rejection in kidney transplantation. Transplant Proc 31:1302-1303
22. 22. Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB (1989) Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509-1515
23. 23. Kormendi F, Amend WJ Jr (1988) The importance of eosinophil cells in kidney allograft rejection. Transplantation 45: 537-539
24. 24. Lajoie G, Madasdy T, Laszik Z, Blick KE, Silva FG (1996) Mast cells in acute cellular rejection of human renal allografts. Mod Pathol 9:1118-1125
25. 25. Lemstrom K, Koskinen P, Hayry P (1995) Molecular mechanisms of chronic renal allograft rejection. Kidney Int (Suppl) 52:S2-S10
26. 26. Ly QY, Raza Ahmad A, MacAulay MA, Lalonde LD, Rowden G, Trethewey E, Dean S (1992) The relationship of mast cells and their secreted products to the volume of fibrosis in post-transplant hearts. Transplantation 53:1047-1051
27. 27. Maryniak RK, First MR, Weiss MA (1985) Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int 27:799-806
28. 28. Monaco AP, Burke JF Jr, Ferguson RM, Halloran PF, Kahan BD, Light JA, Matas AJ, Solez K (1999) Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Am J Kidney Dis 33:150-160
29. 29. Nagler A, Segal V, Slavin S, Levi-Schaffer F (1995) Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts. Clin Exp Immunol 100: 529-535
30. 30. Nicholson ML, McCulloch TA, Harper SJ, Wheatley TJ, Edwards CM, Feehally J, Furness PN (1996) Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation. Br J Surg 83: 1082-1085
31. 31. Nilsson G, Metcalfe DD (1996) Contemporary issues in mast cell biology. Allergy Asthma Proc 17:59-63
32. 32. Pardo-Mindan FJ, Salinas-Madrigal L, Idoate M, Garola R, Sola I, French M (1992) Pathology of renal transplantation. Semin Diagn Pathol 9:185-199
33. 33. Paul LC, Häyry P, Foegh M, Dennis MJ, Miharsch MJ, Larsson E, Fellström B (1993) Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and Kidney transplants. Transplant Proc 25:2022-2023
34. 34. Ruger BM, Hasan Q, Greenhill NS, Davis PF, Dunbar PR, Neale TJ (1996) Mast cells and type VIII collagen in human diabetic nephropathy. Diabetologia 39:1215-1222
35. 35. Ruoss SJ, Hartaman T, Caughey GH (1991) Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88: 493-499
36. 36. Shoskes DA, Parfrey NA, Halloran PF (1990) Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 49:201-207
37. 37. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozuni K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, von Villebrand E, Yamaguchi Y (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411-422
38. 38. Solez K, Benediktsson H, Cavallo T, Croker B, Demetris AJ, et al (1996) Report of the Third Banff Conference on Allograft Pathology (20-24 July 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 28:441-444
39. 39. Suga M, Yamasaki H, Nakagawa K, Kohrogi H, Ando M (1997) Mechanisms accounting for granulomatous responses in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis 14:131-138
40. 40. Walgenbach KJ, Heeckt PF, Stanson JD, Whiteside TL, Bauer AJ (1996) Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. Transplant Proc 28:2454
41. 41. Wood PR, Seow HF (1996) T cell cytokines and disease prevention. Vet Immunol Immunopathol 54:33-44
42. 42. Yousem SA (1997) The potential role of mast cells in lung allograft rejection. Hum Pathol 28:179-182